Summary & Overview
HCPCS G9842: Metastatic Disease at Diagnosis
HCPCS Level II code G9842 designates that a patient has metastatic disease at the time of diagnosis. Nationally, clear documentation of metastatic status is important for accurate clinical records, appropriate care planning, and payer adjudication. This code is used across acute and ambulatory oncology settings to flag advanced disease status that can influence treatment pathways and coverage decisions.
Analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical meaning and typical use cases, plus information on payer coverage considerations and common billing contexts. Benchmarks, policy updates where available, and the clinical context of using a staging/status code in service lines such as oncology and hospital-based care are summarized.
The publication summarizes how G9842 is applied in documentation and billing workflows, highlights payer-specific considerations, and identifies where additional coding or clinical documentation is commonly required. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9842 indicates patient has metastatic disease at diagnosis. This code documents the clinical status of a patient identified at the time of initial diagnosis as having metastatic disease.
-
Service type: Clinical documentation of disease stage/status
-
Typical site of service: Hospital inpatient, hospital outpatient, oncology clinic, or other settings where cancer staging and diagnostic documentation occur
Clinical & Coding Specifications
Clinical Context
A patient presents to an oncology clinic after initial workup identifies metastatic cancer at the time of diagnosis. Typical presentation includes weight loss, new onset pain, or incidental findings on imaging prompting staging. Initial encounter documents biopsy-proven primary malignancy with radiographic evidence of distant metastatic disease (for example, liver or lung lesions for colorectal or breast primaries). The clinical workflow includes history and physical, review of imaging (CT, PET-CT, MRI as indicated), pathology confirmation, multidisciplinary tumor board discussion, staging and prognosis counseling, and initiation of systemic therapy or palliative measures. Coding staff capture the HCPCS Level II code G9842 to indicate the presence of metastatic disease at diagnosis on claims and in quality reporting. Encounters occur in outpatient oncology clinics, hospital outpatient departments, and infusion centers; typical involved providers are medical oncologists, surgical oncologists, radiation oncologists, and oncology advanced practice providers. Documentation supporting G9842 includes imaging reports, pathology, staging notes, and treatment plans reflecting management decisions influenced by metastatic disease at presentation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |